Key result
Rhythmic handgrip exercise blunts neuropeptide Y-mediated vasoconstriction compared to nitroprusside control.
Why the study?
Neuropeptide Y is released from sympathetic nerves during exercise, but whether neuropeptide Y-mediated vasoconstriction is sensitive to metabolic inhibition in humans was unknown.
Does dynamic handgrip exercise attenuate neuropeptide Y-mediated vasoconstriction (functional sympatholysis) to a similar degree as α1-adrenergic vasoconstriction in healthy adults?
Does dynamic handgrip exercise attenuate neuropeptide Y-mediated vasoconstriction (functional sympatholysis) to a similar degree as α1-adrenergic vasoconstriction in healthy adults?
This study demonstrates for the first time in humans that potent vasoconstriction mediated by neuropeptide Y is sensitive to metabolic inhibition during exercise (functional sympatholysis) to a similar extent as alpha-1-adrenergic vasoconstriction.
Answers are grounded in this paper and cite their sources.
Dynamic exercise attenuates NPY vasoconstriction in healthy adults; extends sympatholysis to co-transmitters but leaves open clinical translation.
Metabolic inhibition of sympathetic vasoconstriction (functional sympatholysis) is essential for adequate perfusion of skeletal muscle during exercise. Neuropeptide Y (NPY) is a neurotransmitter that elicits potent vasoconstriction and is co‐released with noradrenaline during sympathoexcitation. NPY is released from sympathetic nerves during exercise; however, no study has assessed whether NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans. We tested the hypothesis that post‐junctional NPY‐mediated vasoconstriction would be sensitive to metabolic inhibition during handgrip exercise to a similar degree as α 1 ‐adrenergic vasoconstriction. In 12 healthy adults (seven male, age: 30 ± 7 years, body mass index: 24.9 ± 3 kg/m 2 ) we measured forearm blood flow (Doppler ultrasound), blood pressure (brachial artery catheter) and heart rate, and calculated changes in forearm vascular conductance (FVC) to local intra‐arterial infusions of phenylephrine (PE; α 1 ‐agonist) or NPY (Y1R‐agonist) during: (1) intra‐arterial infusion of sodium nitroprusside (SNP; nitric oxide donor), a non‐metabolic vasodilatory control, and (2) dynamic rhythmic handgrip exercise (EX; 15% maximal voluntary contraction). As expected, the vasoconstrictor response to PE was attenuated during handgrip exercise compared to SNP (ΔFVC: SNP: −44 ± 25% vs . EX: −17 ± 9%; P = 0.002). Similarly, NPY‐mediated vasoconstriction was blunted during handgrip exercise compared to SNP (ΔFVC: SNP: −32 ± 22% vs . EX: −11 ± 7%; P = 0.029). There was no difference in the magnitude of sympatholysis between PE and NPY (PE: 68 ± 18 vs . NPY: 52 ± 34%; P = 0.28). NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans, and the magnitude of sympatholysis is not different from α 1 ‐adrenergic vasoconstriction. image Key points Neuropeptide Y (NPY) is a neurotransmitter that is co‐released from sympathetic nerve terminals and elicits potent vasoconstriction, particularly during periods of sympathoexcitation. NPY is released from sympathetic nerves during exercise, but it is currently unclear whether NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans (i.e. functional sympatholysis). For the first time we have shown that NPY‐mediated vasoconstriction is sensitive to metabolic inhibition during exercise in healthy adults, and that the magnitude of inhibition is similar to the inhibition observed for α 1 ‐adrenergic mediated vasoconstriction.
No takes yet. Share an insight, caveat, or question.
Wakeham et al. (2025) studied Healthy adults (physiological study of functional sympatholysis) (n=12). Local intra-arterial infusion of Neuropeptide Y (NPY) and Phenylephrine (PE) during rhythmic handgrip exercise (15% MVC) vs. Local intra-arterial infusion of NPY and PE during non-metabolic vasodilatation with sodium nitroprusside (SNP) flow-matched to exercise was evaluated on Percentage change in forearm vascular conductance (ΔFVC) to intra-arterial NPY infusion during handgrip exercise vs sodium nitroprusside (p=0.029). Neuropeptide Y-mediated vasoconstriction was blunted during rhythmic handgrip exercise compared to sodium nitroprusside control.
Synapse has enriched 10 related papers. Consider them for comparative context: